What is Lexaria Bioscience Corp. Common Stock's Market Cap?

Lexaria Bioscience Corp. Common Stock's Market Cap is $163.6M, based on as-reported figures from SEC (XBRL) filings.

What is Lexaria Bioscience Corp. Common Stock's Price / Sales?

Lexaria Bioscience Corp. Common Stock's Price / Sales is 843.3×, based on as-reported figures from SEC (XBRL) filings.

What is Lexaria Bioscience Corp. Common Stock's Revenue (TTM)?

Lexaria Bioscience Corp. Common Stock's Revenue (TTM) is $194.0K, based on as-reported figures from SEC (XBRL) filings.

What is Lexaria Bioscience Corp. Common Stock's Net Income (TTM)?

Lexaria Bioscience Corp. Common Stock's Net Income (TTM) is -$7.7M, based on as-reported figures from SEC (XBRL) filings.

What is Lexaria Bioscience Corp. Common Stock's EBITDA?

Lexaria Bioscience Corp. Common Stock's EBITDA is -$7.7M, based on as-reported figures from SEC (XBRL) filings.

What is Lexaria Bioscience Corp. Common Stock's Diluted EPS (TTM)?

Lexaria Bioscience Corp. Common Stock's Diluted EPS (TTM) is -0.31, based on as-reported figures from SEC (XBRL) filings.

What is Lexaria Bioscience Corp. Common Stock's EBITDA Margin?

Lexaria Bioscience Corp. Common Stock's EBITDA Margin is -3946.4%, based on as-reported figures from SEC (XBRL) filings.

Lexaria Bioscience Corp. Common Stock (LEXX) Financial Statements

Lexaria Bioscience Corp. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SBJ1Q1

XNAS · usd

6.60▼ 2.77 (-29.56%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close9.37

Day's Range6.41 – 9.52

52-Week Range0.35 – 14.37

Volume73.0K

Avg Volume109.5K

Share Statistics

Shares Outstanding

Employees7

ExchangeXNAS

Listed2006-09-08

Share count as of July 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Lexaria Bioscience Corp. Common Stock (LEXX)

What is Lexaria Bioscience Corp. Common Stock's Market Cap?: Lexaria Bioscience Corp. Common Stock's Market Cap is $163.6M, based on as-reported figures from SEC (XBRL) filings.
What is Lexaria Bioscience Corp. Common Stock's Price / Sales?: Lexaria Bioscience Corp. Common Stock's Price / Sales is 843.3×, based on as-reported figures from SEC (XBRL) filings.
What is Lexaria Bioscience Corp. Common Stock's Revenue (TTM)?: Lexaria Bioscience Corp. Common Stock's Revenue (TTM) is $194.0K, based on as-reported figures from SEC (XBRL) filings.
What is Lexaria Bioscience Corp. Common Stock's Net Income (TTM)?: Lexaria Bioscience Corp. Common Stock's Net Income (TTM) is -$7.7M, based on as-reported figures from SEC (XBRL) filings.
What is Lexaria Bioscience Corp. Common Stock's EBITDA?: Lexaria Bioscience Corp. Common Stock's EBITDA is -$7.7M, based on as-reported figures from SEC (XBRL) filings.
What is Lexaria Bioscience Corp. Common Stock's Diluted EPS (TTM)?: Lexaria Bioscience Corp. Common Stock's Diluted EPS (TTM) is -0.31, based on as-reported figures from SEC (XBRL) filings.
What is Lexaria Bioscience Corp. Common Stock's EBITDA Margin?: Lexaria Bioscience Corp. Common Stock's EBITDA Margin is -3946.4%, based on as-reported figures from SEC (XBRL) filings.